WhiteBook2_Part2 - 15
Results
EU trials/epidemiological studies/networks/surveys and primary prevention were, on
average, the most highly ranked research areas in terms of feasibility to conduct (Figure 6).
EU trials/epidemiological studies/networks/surveys was ranked higher than biobanking/
surveillance by 22 out of 33 societies. Furthermore, primary prevention was ranked most
feasible by 8 societies (24%) (Figure 7). Biomarkers/profiling/genetics and medical training
were each ranked most feasible by 5 societies (15%). EU trials/epidemiological studies/
networks/surveys was ranked most feasible by 4 societies (12%).
Figure 6.
Average rankings of research areas in terms of feasibility to conduct
EU trials/epidemiological studies/networks/surveys
Life−style/nutrition/diet/obesity
Primary prevention
Hi−tech imaging/artificial intelligence
Microbiota−host interaction/immunity
Biomarkers/profiling/genetics
Medical training
Gut−brain interaction/enteric nervous system/neural controls
Precision/personalised medicine
Biobanking/surveillance
Source: authors' compilation using sur vey data from UEG national society members .
Note: Lower mean rank values indicate more preferred research areas.
2
Mean rank
4
6
Figure 7.
Proportion of societies that ranked each research area as most feasible
Primary prevention
Biomarkers/profiling/genetics
Medical training
EU trials/epidemiological studies/networks/surveys
Hi−tech imaging/artificial intelligence
Life−style/nutrition/diet/obesity
Microbiota−host interaction/immunity
Precision/personalised medicine
Biobanking/surveillance
Gut−brain interaction/enteric nervous system/neural controls
Source: authors' compilation using sur vey data from UEG national society members .
White Book 2: Part 2
12
WhiteBook2_Part2
Table of Contents for the Digital Edition of WhiteBook2_Part2
WhiteBook2_Part2 - 1
WhiteBook2_Part2 - 2
WhiteBook2_Part2 - 3
WhiteBook2_Part2 - 4
WhiteBook2_Part2 - 5
WhiteBook2_Part2 - 6
WhiteBook2_Part2 - 7
WhiteBook2_Part2 - 8
WhiteBook2_Part2 - 9
WhiteBook2_Part2 - 10
WhiteBook2_Part2 - 11
WhiteBook2_Part2 - 12
WhiteBook2_Part2 - 13
WhiteBook2_Part2 - 14
WhiteBook2_Part2 - 15
WhiteBook2_Part2 - 16
WhiteBook2_Part2 - 17
WhiteBook2_Part2 - 18
WhiteBook2_Part2 - 19
WhiteBook2_Part2 - 20
WhiteBook2_Part2 - 21
WhiteBook2_Part2 - 22
WhiteBook2_Part2 - 23
WhiteBook2_Part2 - 24
WhiteBook2_Part2 - 25
WhiteBook2_Part2 - 26
WhiteBook2_Part2 - 27
WhiteBook2_Part2 - 28
WhiteBook2_Part2 - 29
WhiteBook2_Part2 - 30
WhiteBook2_Part2 - 31
WhiteBook2_Part2 - 32
WhiteBook2_Part2 - 33
WhiteBook2_Part2 - 34
WhiteBook2_Part2 - 35
WhiteBook2_Part2 - 36
WhiteBook2_Part2 - 37
WhiteBook2_Part2 - 38
WhiteBook2_Part2 - 39
WhiteBook2_Part2 - 40
WhiteBook2_Part2 - 41
WhiteBook2_Part2 - 42
WhiteBook2_Part2 - 43
WhiteBook2_Part2 - 44
WhiteBook2_Part2 - 45
WhiteBook2_Part2 - 46
WhiteBook2_Part2 - 47
WhiteBook2_Part2 - 48
WhiteBook2_Part2 - 49
WhiteBook2_Part2 - 50
WhiteBook2_Part2 - 51
WhiteBook2_Part2 - 52
WhiteBook2_Part2 - 53
WhiteBook2_Part2 - 54
WhiteBook2_Part2 - 55
WhiteBook2_Part2 - 56
https://www.nxtbookmedia.com